Cns Pharmaceuticals Inc

NASDAQ:CNSP   3:31:41 PM EDT
1.84
+0.02 (+0.82%)
Products, Other Pre-Announcement

CNS Pharmaceuticals Begins Manufacturing Of Berubicin In Europe

Published: 10/09/2020 12:20 GMT
CNS Pharmaceuticals, Inc. (CNSP) - Cns Pharmaceuticals Begins Manufacturing of Berubicin in Europe.
Cns Pharmaceuticals Inc - Implemented a Dual-track Drug Product Manufacturing Strategy.
Cns Pharmaceuticals - Engaged 2 Separate Manufacturers for Berubicin on Different Continents, Both Pharmaceutics International, Inc., Bsp.
Cns Pharmaceuticals Inc - Bsp and Pii Have Now Begun Manufacturing of Berubicin.
Cns Pharmaceuticals Inc - Expects to Complete Manufacturing at Both Locations Early in Q4.